TIA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.03062003375953E-12 |
Normal-vs-Stage2 |
9.14150000141944E-08 |
Normal-vs-Stage3 |
3.52630002975474E-09 |
Normal-vs-Stage4 |
4.22750001671801E-09 |
Stage1-vs-Stage2 |
5.203900E-02 |
Stage1-vs-Stage3 |
2.430000E-01 |
Stage1-vs-Stage4 |
4.410800E-01 |
Stage2-vs-Stage3 |
3.666400E-01 |
Stage2-vs-Stage4 |
2.051400E-01 |
Stage3-vs-Stage4 |
7.041400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6278089987054E-12 |
Normal-vs-AfricanAmerican |
9.49729994648152E-09 |
Normal-vs-Asian |
8.194200E-04 |
Caucasian-vs-AfricanAmerican |
2.428500E-02 |
Caucasian-vs-Asian |
1.936060E-03 |
AfricanAmerican-vs-Asian |
4.840100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.8421709430404E-14 |
Normal-vs-Female |
9.99200722162641E-16 |
Male-vs-Female |
2.813400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.524000E-03 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.66440194959705E-11 |
Normal-vs-Age(81-100Yrs) |
2.580200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.703800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.820600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.090800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116010E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.378400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.519200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.35759997372298E-09 |
Normal-vs-Grade 2 |
2.24265050974282E-14 |
Normal-vs-Grade 3 |
2.0925483568135E-12 |
Normal-vs-Grade 4 |
1.92619999994648E-06 |
Grade 1-vs-Grade 2 |
4.334600E-01 |
Grade 1-vs-Grade 3 |
2.750000E-01 |
Grade 1-vs-Grade 4 |
9.215600E-02 |
Grade 2-vs-Grade 3 |
5.398600E-01 |
Grade 2-vs-Grade 4 |
1.329760E-01 |
Grade 3-vs-Grade 4 |
3.333600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.64634972321664E-12 |
Normal-vs-ccB subtype |
3.54730000928782E-09 |
ccA subtype-vs-ccB subtype |
3.849400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.54791801177635E-15 |
Normal-vs-N1 |
2.530200E-02 |
N0-vs-N1 |
3.907200E-01 |
|
|